The lncRNA SLC16A1-AS1 has previously been found to be upregulated in osteosarcoma, glioblastoma, and oral squamous cell carcinoma [50,52,63]; downregulated in non-small cell lung cancer and cervical squamous cell carcinoma [26,56]; and show conflicting expression profiles in hepatocellular carcinoma [51,53,54]. This evidence concerns the gene SLC16A1 and oral cavity squamous cell carcinoma.